Suppr超能文献

钙通道阻滞剂与老年人

Calcium-channel blockers and the elderly.

作者信息

Ryan C

机构信息

San Francisco Heart Institute, Seton Medical Center, Daly City, CA 94015.

出版信息

Compr Ther. 1990 Jun;16(6):51-4.

PMID:2373003
Abstract

Calcium-channel blockers may well be the drugs of choice for treating angina, hypertension, and supraventricular arrhythmia in the elderly. They are effective, have no serious side effects, and when wisely matched to the patient, are very well tolerated. Most calcium-channel blockers can be administered once or twice daily. A choice of four is available; only verapamil and diltiazem hydrochloride are useful for supraventricular arrhythmia. All four, however, are effective for the treatment of hypertension and angina. Expanding uses of calcium-channel blockers include peripheral vascular disease and migraine. There may be a theoretical advantage in humans from the point of view of the anti-atherosclerosis demonstrated in animals.

摘要

钙通道阻滞剂很可能是治疗老年人心绞痛、高血压和室上性心律失常的首选药物。它们疗效显著,没有严重副作用,并且在合理匹配患者的情况下,耐受性良好。大多数钙通道阻滞剂可以每日服用一次或两次。有四种可供选择;只有维拉帕米和盐酸地尔硫䓬对室上性心律失常有效。然而,这四种药物对高血压和心绞痛的治疗均有效。钙通道阻滞剂的应用范围不断扩大,包括外周血管疾病和偏头痛。从动物实验中显示的抗动脉粥样硬化作用来看,在人类身上可能存在理论上的优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验